CMBA
TARO

C.M. Bidwell & Associates’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

C.M. Bidwell & Associates’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,155
Closed -$73K – 653
2021
Q3 		$73K Buy
+1,155
New +$79.9K 0.05% 263
2018
Q3 		– Sell
-815
Closed -$94K – 470
2018
Q2 		$94K Buy
+815
New +$89.5K 0.09% 195

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

C.M. Bidwell & Associates's TARO Position: Q4 2021 in Review

C.M. Bidwell & Associates sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2021, closing a stake of 1,155 shares — an estimated $73K sold.

C.M. Bidwell & Associates first reported a position in TARO in Q2 2018 and held it in 2 quarters. The position peaked at $94K in Q2 2018. 71 funds tracked by Wall St. Rank hold TARO as of Q4 2021.

  • C.M. Bidwell & Associates reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2021 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,155 Taro Pharmaceutical Industries Ltd. shares in Q4 2021, an estimated $73K.
  • C.M. Bidwell & Associates first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2018 and held it in 2 quarters.
  • C.M. Bidwell & Associates's Taro Pharmaceutical Industries Ltd. position peaked at $94K in Q2 2018.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2021, filed 11 Feb 2022.